Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Jurnal Biologi Tropis
Lisnasari, Baiq Risky
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Immunology & microbiology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
In Silico Evaluation of Typhonium flagelliforme Fatty Acids for Cdc25B Inhibition and Chemotherapy Synergistic Potential Lisnasari, Baiq Risky; Maulidya, Selvira Anandia Intan
Jurnal Biologi Tropis Vol. 25 No. 3 (2025): Juli-September
Publisher : Biology Education Study Program, Faculty of Teacher Training and Education, University of Mataram, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jbt.v25i3.9319

Abstract

Typhonium flagelliforme exhibits cytotoxic activity against various cancer cell lines, including breast cancer. This study employed an in silico approach to evaluate the potential interaction or synergy between its fatty acid derivatives—2-octenoic acid and 2-hexenoic acid—and standard cytotoxic agents in breast cancer therapy. SwissTargetPrediction was used to identify the putative molecular targets of the compounds. Molecular docking was performed against phosphatase Cdc25B (PDB ID: 1CWR) using CB-Dock2, and pharmacokinetic properties were evaluated using SwissADME. Both 2-octenoic acid and 2-hexenoic acid were predicted to target Cdc25A and Cdc25B, which are key regulators of cell cycle progression. Molecular docking revealed binding affinities of −4.42 and −4.60 kcal/mol, respectively, compared to −5.97 kcal/mol for the native inhibitor NSC 663284. These compounds shared multiple key residues in the binding pocket, although they formed fewer hydrogen bonds. Pharmacokinetic predictions showed high gastrointestinal absorption, blood–brain barrier permeability, and no inhibition of major cytochrome P450 enzymes, suggesting minimal interaction with the metabolic pathways of standard chemotherapeutics. The results suggest that T. flagelliforme metabolites may not interfere with cytotoxic drug metabolism but could provide a synergistic effect by targeting cell cycle regulators.
Co-Authors Maulidya, Selvira Anandia Intan